Inmune Bio, Inc. (INMB) — 10-K Filings

10-K Filings (2)

• Inmune Bio, Inc. Files 2024 Annual Report — Mar 27, 2025 Risk: medium
  Inmune Bio, Inc. filed its 10-K for the fiscal year ended December 31, 2024, reporting on its operations as a biotechnology company focused on biological produc
• Inmune Bio, Inc. Files 2023 Annual Report on Form 10-K — Mar 28, 2024 Risk: low
  Inmune Bio, Inc. (INMB) filed a Annual Report (10-K) with the SEC on March 28, 2024. Inmune Bio, Inc. filed its annual report for the fiscal year ended December

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX